Upload
others
View
6
Download
1
Embed Size (px)
Citation preview
Annual Product Quality Review
(APQR)
Dr. A. Amsavelwww.bp
harm
anote
s.com
“You tell me,…and I forget.
You teach me,…and I remember.
You involve me,…and I learn.”
- BENJAMINFRANKLINwww.bpha
rman
otes.c
om
Introduction
• Quality Unit• APQR
– Requirement– Responsibility– Documents and data required– Preparation and evaluation– Conclusion
www.bpha
rman
otes.c
om
ICH Q7- 2.0 Quality Management
•
•
•••
1. Principles– Define Responsibilities & Authorities
2. Responsibilities of Quality Unit (s)– Quality Control / Assurance, Independent of Production
3. Responsibilities of Productionactivities4. Internal Audits (self Inspection)5. Product Quality Review
www.bpha
rman
otes.c
om
Quality Assurance responsibilities :
•
•
•
•
•
•
•
Releasing or rejecting all APIs and intermediates for outsideuse
Establishing a system to release or reject raw materialintermediates, packaging and labelling materials ;
Reviewing completed batch production and laboratory control records of critical processstepsMaking sure that critical deviations are investigated and resolved;
Approving all specifications and master production instructions;
Approving all procedures impacting the quality of intermediates or APIs;
Making sure that effective systems are used for maintainingand calibrating critical equipment ;
www.bpha
rman
otes.c
om
Questions?
• What is an annual product review?• What is the objective ofAPR?• Who is responsible?• What is procedure & reference forAPQR?• What are the data must be presented inan
annual product review?• How should an annual product reviewbe
organized?• Review and conclsion
www.bpha
rman
otes.c
om
Annual Product Review - WHAT
Directive Statement:An Annual Product Review must be conducted for
each commercial product. The purpose of this annual review is to verify the consistency of the process, to assess trends, to determine the need for changes in specification, production, manufacturing and/or control procedures and to evaluate the need forrevalidation.
Annual Product Reviews (APRs) are important for communication between manufacturing, quality and regulatory Affairs, to enable quality improvement processes. Content and management of AnnualProduct Reviews must be established according to thisdirective.
www.bpha
rman
otes.c
om
Reference - APQR
• US FDA –Published in 1978 GMP Guideline which was included to review the qualitystandards
• All GMP Guidelines refer the requirement ofAPQR– CFR 211.180 (e):– ICHQ7– EUGMP– WHO- GMP www.bp
harm
anote
s.com
Requirement of APQR
• In USA - "Annual ProductReview“• In Europe, the EU GMP Guideline uses the
term "Product QualityReview".• Requirement or expectations are almostsame• APQR should be conducted for all commercial
product.• APQR should confirm the State ofControlwww.bp
harm
anote
s.com
The US Requirements: 21 CFR 211.180 (e)
• US FDA objectives for performing the APR are to determine the need to make changes inthe– manufacturing process,– the manufacturing controls (e.g., in-process testingand
monitoring), evaluate the needs for revalidationand– product specifications.
to evaluate the compliance status of the manufacture and to identify areas ofimprovement
A review of a representative number of batches, whether approved or
rejected, and records associated with thebatch
A review of complaints, recalls, returned or salvageddrug products,
and investigations conducted under Sec. 211.192 for each drug
product.
www.bpha
rman
otes.c
om
The Requirements for APIs in ICHQ7
2.5 Product Quality Review
2.50 Regular quality reviews of APIs should be conducted with the objective
of verifying the consistency of the process. Such reviews should normally be
conducted and documented annually and should include at least:
A review of critical in-process control and critical API test results;A review of all batches that failed to meet established specification (s); A review of all critical deviations or non-conformances and related investigations;A review of any changes carried out to the processes or analytical methods;A review of results of the stability monitoring program;A review of all quality-related returns, complaints and recalls; and A review of adequacy of corrective actions
www.bpha
rman
otes.c
om
The Requirements for APIs in ICHQ7
2.5 Product Quality Review
2.51 The results of this review should be evaluated and an
assessment made of whether corrective actions or any
revalidation should be undertaken. Reasons for such corrective
action should be documented. Agreed corrective actions should
be completed in a timely and effective manner.www.bpha
rman
otes.c
om
The EU Requirements for PQR(1)
• EUGuidelines to Good Manufacturing Practice ; MedicinalProducts for Human and Veterinary Use ; Part I ; Chapter 1Quality Management (issued on 25 October2005)
Product Quality Review1.5 Regular periodic or rolling quality reviews of all licensed medicinal products, including export only products, should be conducted with the objective of verifying consistency of the existing process, the suitability of current specifications for both starting materials and finished product to highlight any trends and to identify productand process improvements. Such reviews should normally be conducted and documented annually, taking into account previous reviews, and should include atleast:
www.bpha
rman
otes.c
om
The EU Requirements for PQR(2)
•
••
•
•
•
A review of starting materials and packaging materials used for the product, especially those from newsourcesAreview of critical in- process controls and finished product resultsAreview of all batches that failed to meet established specification(s) and their investigation.A review of all significant deviations or non conformances, their related investigations, and the effectiveness of resultantcorrective and preventative actions takenAreview of all changes carried out to the processes or analytical methodsA review of Marketing Authorisation variations submitted/granted/refused, including those for thirdcountry (export only) dossiers.
www.bpha
rman
otes.c
om
The EU Requirements for PQR(3)
•
•
•
•
•
Areview of the results of the stability monitoring programme and any adverse trendsA review ofall quality- related returns, complaints and recalls and the investigations performed at thetimeA review of adequacy of any other previous productprocess or equipment corrective actions. For new marketing authorisations and variations to marketing authorisations, a review of post-marketingcommitmentsThe qualification status of relevant equipment andutilities,e.g. HVAC, water, compressed gases, etcA review of Technical/Quality Agreements to ensure that they are up to date.
www.bpha
rman
otes.c
om
Benefit or use
•••••••
Decrease the risk of out-of-specificationresults Minimize the risk of rework/reprocessing Decrease downtime
Increase productivityDecrease the risk of productrecallsMeet all regulatorycommitments/requirementsImprove communication between production,engineering, quality and regulatory functionswww.bp
harm
anote
s.com
Responsibilities
•••
••
•
•
It is responsibilities ofQAEstablish an SOP with responsibility and process ofAPQRIndividual departments have toprovide the data and participating in the APQRprocess.Reviews should normally be conducted anddocumentedThe Quality Unit, as the central position, should requestthis review and coordinate the necessary work. Can develop format/ check list to get information.Other departments, like Production, Engineering, Maintenance, Purchase, etc. are also need to beinvolved.Senior Quality Management must approve theAPQR.
www.bpha
rman
otes.c
om
Requirements
••
•••
••
•
•
Written procedures shall be established and it must be followed ;APQR must cover a one-year rolling period, but does not haveto coincide with a calendaryearThe review should normally be completed within 60 calendardays APQR for all productsmanufacturedIn case product not manufactured in the year of review ,shall review stability and complaint, Recall & returns etc.APQR must be prepared for each water quality gradeproducedFor critical utilities it is recommending either to perform a separate APR or to include a specific chapter in theAPR.APQR must include all batches of product (accepted/rejected/destroyed )APQR must address the assessment of data, documents and electronic records reviewed
www.bpha
rman
otes.c
om
Preparation
Appropriate statistical tools may be used to assess process capability when data from a
large number of batches is beingreviewed.
Where the data concludes that there is adrift in process capability , actions should
be determined to evaluate the causes and improve performance in the forthcoming
reviewperiod.
Thereview of all batches which fail to meet specification and the review of critical
deviations
should look specifically at recurring causes and identifyappropriate actions to
reduce the frequency and improveperformance.
•
•
•
•
www.bpha
rman
otes.c
om
Corrective action
Equipment not functioning correctly or in need of maintenance or replacement.
Inadequate batch instructions or training ofoperators.
Process parameters so tightly defined that the equipmentis not capable of routinely
achieving the acceptancecriteria.
Inhomogeneous product or inadequate samplingprocedures.
Poor quality raw materials or lack of control of raw material suppliers.
Retest period or expirydate
Revalidation,requalification
•
••
•••
••
www.bpha
rman
otes.c
om
Review and document
••
•
Review must include, at a minimumReview of any recommendations and actions taken from prior report"Basicstatistics" Number of batches manufactured, including partiallycompleted
batches and corresponding yields Number and percentage of batches rejected, reworked orreprocessed
and related reasons Critical in-process controls, finished product results and criticalAPI
test results www.bpha
rman
otes.c
om
Review and document
• Review of "deviations from the validated state“ Areview of all batches that failed to meet established specification(s) and
their investigation
Significant/critical deviations, Out of Specification Results and relatedfailure investigations (review of adequacy and effectiveness of corrective and preventative actions taken)
Product quality complaints &ProductRecalls
Quality related issues for returned, and/orsalvaged goods
Changes effected (change control) and variations during the period (e.g. process, suppliers, equipment, critical utilities)
Changes of product specifications or methods (e.g. analytical changes,and results)
www.bpha
rman
otes.c
om
Review and document
•••••••••••
Effectiveness of implementation ofCAPA out of calibrationresults;Process and analytical equipment retirement; Water quality ;Validation carried out in process and analyticalmethod; results of the stability monitoringprogram;Environment monitoring (bio-burden) in the cleanroom; Yield output variations;return goods and salvage of product; Retain sampleRegulatory issues if any
www.bpha
rman
otes.c
om
Review and document
•
•
•
•
•
TrendAnalysis Trend analysis on key in-process and release testing with graphic
representation and basic statisticsrecommended
A review of the results of the stabilitymonitoring program and trend
analysis on stabilitydata
Observations/Recommendations an conclusion Report the reviewobservations.
Recommendations from thisreview
The results of the APR must be evaluated and an assessment made whether corrective or preventive action or any re-validationis necessary.A conclusion statement must be written to assess if the product consistently meets its quality attributes, and if not, what actions need to be taken.Rationale for such CAPAs must bedocumented.
www.bpha
rman
otes.c
om
Data collectionS.No
Batch number% MC
%Assay
Related substances by GC
Imp-A Imp-K Sum of impurities
Volatile substances by GC
Methanol Toluene
54 XXYYZZZ 0.28 100.1 0.06 0.00 0.00 0.10 0.00
www.bpha
rman
otes.c
om
TrendChart%Asay
XXXXXX Batch Vs % of Assay106
1 4 7 10 13 16 19 22 25 28
% Assy
MeanStandard Deviation Minimum MaximumRSD
Natural specification Limit
( µ ± 3σ)
Specification or Parameter Range
104 USL
102 UNSL
100 MEAUNpper limit
98Assay
LNSL96 LSL
9431 34 37 40 43 46 49 52 55 58 61 64 67 70 73 76 79 82 85
Batch Number
: 99.8: 0.1: 99.5: 100.1: 0.1
LowerLimit : 99.4
Upper Limit : 100.2
: 98.0-102.0%
www.bpha
rman
otes.c
om
TrendChart
www.bpha
rman
otes.c
om
Processcapability
Process consistency can be established by CpkProcess capability index (Cpk) can be calculated as below;
SU-SL
CPk = ---------3σ
x - SL
or CP=---------
One sided specification SU– x
CPk=----------3σ 3σ
1.33 ≤CPk Satisfiable enough
1.00 ≤CPk < 1.33 Adequate
CPk <1.00 Inadequate
www.bpha
rman
otes.c
om
Process consistency-Yield
Yield range : 100 -120kg Std deviation : 3.0Mean : 110kg
= 1.1120
Cpk =------------6*3.0
After change made in theprocess
and mean 112kg
= 1.515
Std deviation : 2.220
Cpk =------------6*2.2
www.bpha
rman
otes.c
om
Normal distribution
Normal Distribution:µ ± σ = 68.3% µ± 2σ = 95.4% µ± 3σ = 99.7%
www.bpha
rman
otes.c
om
Stability trend
%Assay MeanStandard Deviation MinimumMaximum RSD
Natural specification Limit LowerLimitUpperLimit
: 99.7%: 0.1%: 99.4%: 99.9%: 0.1%
: 99.3%
: 100.0%( µ ± 3σ)
Specification or Parameter Range : 99.0 % to 100.5 %
www.bpha
rman
otes.c
om
Review of documents & system
•
•
•
Data collection and reviewManufacturing instructions and packagingprocedures
• Changes compared to the previousyear• Validation status following achange
Batch production records• Actual values for process parameters duringproduction• IPCdata• Deviations• Yield• Rawmaterials
Test procedures• Changes to specifications or methods compared tothe previous
year• Validation status of the testmethods
www.bpha
rman
otes.c
om
Review of documents & system•
•
•
Data collection and review
Quality SystemDeviationsOOS– Failure cause analysis
Vendor status– Change of vendor– Supplier qualification andapproval– Deviations, rejections of rawmaterial
Modification– Changes to the facility– Changes to machines/apparatus– Changes to super ordinate processes
www.bpha
rman
otes.c
om
Review of documents & systemData collection and review
•
•••
Quality attributes (analytical data)– Key starting material/critical material– Critical test result of IPC,intermediates– Critical quality parameters of finishedproduct/blended– Decision on the trend- tightening of spec, CAPA,validation
requirement if any
All quality-related returns, complaints andrecalls Adequacy of correctiveactionsStability data– Changes to packaging material– Process changes
www.bpha
rman
otes.c
om
Inferences from the APR
• Follow-up actions may be included but are not limitedto:
Product process improvement Analytical method improvements
In-process or final product specificationreview Revalidation
Product recall or withdrawal
New packagingwww.bp
harm
anote
s.com
Check List forAPQR
•
•
••
•
•
•
Are there any outstanding validation commitments or correctiveand preventive action plans from last APQR?Are the processes in a validated state or is additional validationwork needed ?Is the qualification status (IQ/OQ/PQ) acceptable?Are all critical aspects performing satisfactorily or arecorrective/ preventive action plans required?Are there any significant findings concerning data trending of the manufacturing process, starting materials, or packaging materials?Are all change controls implemented, and closed? Communicated to the relevant customers and regulatory agencies?Are all change controls, deviations, OOS investigation, complaints are reviewed, investigated, CAPA implemented, andclosed?
www.bpha
rman
otes.c
om
Check List forAPQR
• Are there any significant findingsconcerning– changes performed ?– specifications or test methods?– deviations and non- conformances ?
– out of specification results?
– rejected batches, quality-related returns, customer complaints, orrecalls ?
– the stability monitoring program?
– retain sample examination ?
••
Are all post- marketing commitments to Authorities met ?Are all required Technical Agreements in place andup-to-date ?
www.bpha
rman
otes.c
om
ThankYou
www.bpha
rman
otes.c
om